Paul A Cohen
Overview
Explore the profile of Paul A Cohen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1723
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hardcastle S, Maxwell-Smith C, Cavalheri V, Boyle T, Roman M, Platell C, et al.
Scand J Med Sci Sports
. 2024 Feb;
34(3):e14572.
PMID: 38424471
Introduction: The study examined whether increased physical activity (PA) in nonmetropolitan cancer survivors was maintained 12 weeks following the PPARCS intervention. Methods: PA outcomes were assessed using an accelerometer at...
12.
Kayraklioglu N, Katsakhyan L, Cohen P, Singh N, Rabban J, Matias-Guiu X
Int J Gynecol Pathol
. 2023 Sep;
43(3):242-252.
PMID: 37668357
Long-standing controversial and unresolved issues in the current "International Federation of Gynecology and Obstetrics" staging system for endometrial cancer are well-recognized by pathologists and clinicians alike and exist primarily as...
13.
Fantoni A, Meniawy T, Cohen P, McMullen M
Gynecol Oncol Rep
. 2023 Jul;
48:101246.
PMID: 37520785
Objective: Poly-ADP ribose polymerase inhibitors (PARPi) have expanded the management armamentarium against high grade serous tubo-ovarian cancer (HGSOC) in patients with germline and somatic pathogenic variants (PVs). Germline testing has...
14.
Kelly S, Quenby M, Corcoran T, Webb S, Cohen P
Health Sci Rep
. 2023 Jun;
6(6):e1335.
PMID: 37324247
Background And Aims: Adequate postoperative analgesia and prevention of post-op nausea and vomiting (PONV) are core components of modern day anaesthesia and peri-operative care. As well as contributing to overall...
15.
Schofield C, Lopez P, Cohen P, Taaffe D, Newton R, Galvao D, et al.
Int J Gynecol Cancer
. 2023 May;
33(10):1587-1594.
PMID: 37220950
Objective: Our primary aim was to compare muscle morphology (skeletal muscle mass and density) between patients who underwent primary cytoreductive surgery versus interval cytoreductive surgery for advanced high-grade serous ovarian...
16.
Schofield C, Newton R, Taaffe D, Galvao D, Cohen P, Meniawy T, et al.
Support Care Cancer
. 2023 Apr;
31(5):304.
PMID: 37101013
Objectives: In ovarian cancer (OC), suboptimal muscle morphology (i.e., low muscle mass and density) is associated with poor clinical outcomes, yet little is known about the effect of interventions aimed...
17.
Hardcastle S, Maxwell-Smith C, Cavalheri V, Boyle T, Roman M, Platell C, et al.
J Sport Health Sci
. 2023 Feb;
13(1):81-89.
PMID: 36736725
Background: Physical activity (PA) is important for cancer survivors. Trials of remotely delivered interventions are needed to assist in reaching under-served non-metropolitan cancer survivors. The objective of this study was...
18.
Kang E, Weir A, Meagher N, Farrington K, Nelson G, Ghatage P, et al.
Cancer
. 2022 Dec;
129(5):697-713.
PMID: 36572991
Background: Cyclin E1 (CCNE1) is a potential predictive marker and therapeutic target in tubo-ovarian high-grade serous carcinoma (HGSC). Smaller studies have revealed unfavorable associations for CCNE1 amplification and CCNE1 overexpression...
19.
Cabasag C, Arnold M, Rutherford M, Ferlay J, Bardot A, Morgan E, et al.
Int J Cancer
. 2022 Dec;
152(9):1763-1777.
PMID: 36533660
The aim of the study is to provide a comprehensive assessment of incidence and survival trends of epithelial ovarian cancer (EOC) by histological subtype across seven high income countries (Australia,...
20.